Publication | Closed Access

Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation

InflammationMetabolic Associated SteatohepatitisAnti-inflammatoryHepatologyMedicineLiver PhysiologyCathepsin B InhibitionImmunologyPathologyHepatology InflammationNon-alcoholic SteatohepatitisLiver DiseaseFatty Liver DiseasePharmacologyDrug-induced Liver InjuryCaspase-1 Activation